• Patient-Derived Gastric Cancer Assembloids

  2026-09-17

  Shapira-Netanelov and colleagues developed a patient-derived gastric cancer assembloid system that combines matched tumor organoids with stromal subpopulations from the same tumor. The model reproduced clinically relevant tumor–stroma effects on gene expression and drug sensitivity, providing a more physiologically informative platform for resistance studies and personalized therapeutic research.

• Simvastatin (Zocor) for Lipidomics Assays

  2026-09-17

  Explore Simvastatin (Zocor) as a mechanistically grounded benchmark for lipidomics, hyperlipidemia, and liver cancer assays. This guide connects HMG-CoA reductase inhibition with practical HepG2 experimental design while clarifying what lipidomic changes can—and cannot—demonstrate.

• Carbapenemase Gene Transmission in CREC

  2026-09-16

  A 2025 BMC Microbiology study mapped carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, combining gene localization, conjugation assays, mobile-element profiling, and ERIC-PCR typing. Its findings highlight plasmid-associated blaNDM-1, efficient horizontal transfer, and multidrug resistance as linked surveillance priorities rather than isolated laboratory observations.

• ICI 118,551 Hydrochloride Assay Workflows

  2026-09-16

  ICI 118,551 hydrochloride provides a reversible pharmacological way to interrogate β2-adrenergic receptor signaling in cell, migration, and tissue assays. This guide distinguishes practical starting conditions from stroke-inflammation evidence and shows how to pair receptor blockade with viability, chemotaxis, and orthogonal validation controls.

• Kir2.1 Inhibition in Pulmonary Vascular Remodeling

  2026-09-15

  The reference study identifies Kir2.1 as a functional regulator of pulmonary artery smooth muscle cell proliferation and migration in pulmonary hypertension models. Using in vivo and in vitro approaches, it connects Kir2.1 activity with the TGF-β1/SMAD2/3 pathway and shows how pharmacological inhibition may help dissect mechanisms of pulmonary vascular remodeling.

• Stattic: Practical STAT3 Inhibition Workflows

  2026-09-15

  Stattic provides a mechanism-focused way to test STAT3 dependence in HNSCC, apoptosis, migration, and radiation-response assays. This guide translates product specifications and a lymphangiogenesis study into practical setup, optimization, and troubleshooting decisions.

• HyperScribe™ T7 Cy5 RNA Labeling for TREM2

  2026-09-14

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit enables a practical strategy for visualizing and validating RNA targets associated with TREM2-driven efferocytosis. This article connects Cy5 probe design with the 2026 cleavage-resistant TREM2 study while clarifying what fluorescence-based RNA assays can—and cannot—demonstrate.

• Afatinib in Gastric Cancer Assembloids

  2026-09-14

  Afatinib (BIBW 2992) provides a practical way to interrogate irreversible ErbB signaling in patient-derived gastric cancer assembloids. By comparing matched tumor organoids with stromal co-cultures, researchers can distinguish epithelial drug sensitivity from microenvironment-driven resistance and improve targeted therapy research.

• Vidarabine Monohydrate: Applied Research Workflow

  2026-09-13

  Build more reproducible antiviral assays with Vidarabine monohydrate by controlling DMSO formulation, exposure timing, and orthogonal viral readouts. This workflow adapts a validated screening principle from a protein-interaction study without confusing its neuroscience mechanism with antiviral biology.

• Ibuprofen: Applied Workflows for Cell Research

  2026-09-12

  Build reproducible Ibuprofen experiments around COX-1/COX-2 biology, apoptosis, and cell-cycle measurements rather than relying on viability alone. This practical guide also shows how albumin-binding concepts from a molecular recognition study can improve assay interpretation without overextending the evidence.

• FXR–KLF11 Signaling in Contrast-Induced AKI

  2026-09-11

  The reference study identifies an FXR–KLF11 transcriptional pathway that suppresses JAK2/STAT3 signaling and protects against contrast-induced acute kidney injury in mouse and HK-2 cell models. Its combination of pharmacological treatment, genetic loss-of-function, RNA sequencing, reporter assays, and ChIP experiments provides a mechanistic framework for studying bile acid receptor signaling in renal injury.

• Nano-Granulated Zoledronate Reprograms Immunity

  2026-09-11

  Chen et al. develop Nano-ZD, a lymph-node-directed zoledronate formulation that targets innate immune metabolism rather than bone tissue. The study links CoQ depletion with altered OXPHOS and pyrimidine metabolism, MAVS and inflammasome activation, and stronger vaccine and antitumor responses when combined with MPLA or αPD-L1.

• Tiamulin (Thiamutilin) Assay Workflows

  2026-09-10

  Tiamulin (Thiamutilin) combines ribosome-targeted antibacterial activity with experimentally useful anti-inflammatory effects, making it valuable for pathogen susceptibility, cell-signaling, and veterinary pharmacology studies. This guide translates its binding biology into practical workflows, controls, and troubleshooting strategies for reproducible research.

• hiPSC Intestinal Organoids for Pharmacokinetics

  2026-09-10

  Saito and colleagues developed a direct three-dimensional cluster-culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids could be propagated, cryopreserved, and differentiated into intestinal epithelial cells with enterocyte-associated metabolic and transporter activities, supporting their use in human-relevant pharmacokinetic studies.

• NSC-23766: Rac GTPase Inhibitor Guide

  2026-09-09

  NSC-23766 is a selective Rac GTPase inhibitor that blocks Rac1 activation by Trio and Tiam1-related guanine nucleotide exchange factor interactions. Product and cell-study evidence supports its use in cancer research, endothelial-barrier assays, apoptosis studies, and mechanistic Rac1 signaling experiments.

8005 records 1/534 page Next 12345 下5页 Last page